Product Code: GDME1052EPD
GlobalData's Medical Devices sector report, "Retrovirus Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Retrovirus Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Retrovirus Tests are the diagnostic tests used to detect the antigen/antibody of HIV1, HIV 2 (human immunodeficiency virus) and HTLV I, HTLV II (human T-cell lymphotropic virus) viruses.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Retrovirus Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Retrovirus Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Retrovirus Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
2 Introduction
- 2.1 Retrovirus Tests Overview
3 Products under Development
- 3.1 Retrovirus Tests - Pipeline Products by Stage of Development
- 3.2 Retrovirus Tests - Pipeline Products by Territory
- 3.3 Retrovirus Tests - Pipeline Products by Regulatory Path
- 3.4 Retrovirus Tests - Pipeline Products by Estimated Approval Date
4 Retrovirus Tests - Pipeline Products under Development by Companies
- 4.1 Retrovirus Tests Companies - Pipeline Products by Stage of Development
- 4.2 Retrovirus Tests - Pipeline Products by Stage of Development
5 Retrovirus Tests Companies and Product Overview
6 Retrovirus Tests- Recent Developments
7 Appendix
- 7.1 Methodology
- 7.2 About GlobalData
- 7.3 Contact Us
- 7.4 Disclaimer
List of Tables
List of Tables
- Table 1: Retrovirus Tests - Pipeline Products by Stage of Development
- Table 2: Retrovirus Tests - Pipeline Products by Territory
- Table 3: Retrovirus Tests - Pipeline Products by Regulatory Path
- Table 4: Retrovirus Tests - Pipeline Products by Estimated Approval Date
- Table 5: Retrovirus Tests Companies - Pipeline Products by Stage of Development
- Table 6: Retrovirus Tests - Pipeline Products by Stage of Development
- Table 7: Accelevir Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
- Table 8: Diagnostic Test - Latent HIV-1 Virus - Product Status
- Table 9: Diagnostic Test - Latent HIV-1 Virus - Product Description
- Table 10: Advanced Liquid Logic Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 11: Portable Benchtop Analyzer - Viral Load Assay - Product Status
- Table 12: Portable Benchtop Analyzer - Viral Load Assay - Product Description
- Table 13: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 14: AIMS System - HIV-1 Test - Product Status
- Table 15: AIMS System - HIV-1 Test - Product Description
- Table 16: AtheNA Multi-Lyte System - HIV-1 Test - Product Status
- Table 17: AtheNA Multi-Lyte System - HIV-1 Test - Product Description
- Table 18: Allied Innovative Systems, LLC Pipeline Products & Ongoing Clinical Trials Overview
- Table 19: HIV p24 Antigen ELISA - Product Status
- Table 20: HIV p24 Antigen ELISA - Product Description
- Table 21: Autoimmune Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
- Table 22: Viral Protein Antibody Test - Non-HIV AIDS - Product Status
- Table 23: Viral Protein Antibody Test - Non-HIV AIDS - Product Description
- Table 24: Ayanda Biosystems SA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
- Table 25: DETECTHIV - Product Status
- Table 26: DETECTHIV - Product Description
- Table 27: Biokit SA Pipeline Products & Ongoing Clinical Trials Overview
- Table 28: BIO-FLASH HIV-1+2 Ag/Ab Assay - Product Status
- Table 29: BIO-FLASH HIV-1+2 Ag/Ab Assay - Product Description
- Table 30: Biomagnetics Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview
- Table 31: Diagnostic Test - HIV - Product Status
- Table 32: Diagnostic Test - HIV - Product Description
- Table 33: IOBS - HIV Diagnostic Test - Product Status
- Table 34: IOBS - HIV Diagnostic Test - Product Description
- Table 35: Blackfly Investments LLC Pipeline Products & Ongoing Clinical Trials Overview
- Table 36: Molecular RNA Test - HIV - Product Status
- Table 37: Molecular RNA Test - HIV - Product Description
- Table 38: Calypte Biomedical Corporation Pipeline Products & Ongoing Clinical Trials Overview
- Table 39: Second Generation Incidence Test - HIV - Product Status
- Table 40: Second Generation Incidence Test - HIV - Product Description
- Table 41: CeMines, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
- Table 42: Diagnostic Test - HIV - Product Status
- Table 43: Diagnostic Test - HIV - Product Description
- Table 44: ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview
- Table 45: CD4 Assay - HIV - Product Status
- Table 46: CD4 Assay - HIV - Product Description
- Table 47: Co-Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 48: HIV RNA Real-time PCR Kit - Product Status
- Table 49: HIV RNA Real-time PCR Kit - Product Description
- Table 50: Conrad Pipeline Products & Ongoing Clinical Trials Overview
- Table 51: Biomarker - HIV Acquisition - Product Status
- Table 52: Biomarker - HIV Acquisition - Product Description
- Table 53: Biomarker - Hormonal Contraception - Product Status
List of Figures
List of Figures
- Figure 1: Retrovirus Tests - Pipeline Products by Stage of Development
- Figure 2: Retrovirus Tests - Pipeline Products by Territory
- Figure 3: Retrovirus Tests - Pipeline Products by Regulatory Path
- Figure 4: Retrovirus Tests - Pipeline Products by Estimated Approval Date
